Section 4: Establishment of Review Committee and membership

(1)
For the purposes of the implementation of the List, there is hereby established the National Drug Formulary and Essential Drug List Review Committee (hereinafter referred to as "the Review Committee").
(2) The Review Committee shall consist of the following members to be appointed by the Minister, that is-
(a) two clinical pharmacologists, one of who shall be the chairman;
(b) the Director of Food and Drugs Administration and Control in the Federal Ministry of Health;
(c) the Director of Hospital Services and Training in the Federal Ministry of Health;
(d) the Director of Primary Health Care Programme in the Federal Ministry of Health;
(e) four heads of pharmacy departments appointed from State Ministries of Health so however that not more than one shall be appointed from anyone particular State on zonal rotation;
(f) one representative of the Pharmaceutical Society of Nigeria;
(g) one representative of the Nigerian Medical Association;
(h)
one representative of the Phamaceutical Manufacturers Association of Nigeria; and
(i) two medical practitioners appointed by the Minister.